Metformin Inhibits DNMT3A Clonal Hematopoiesis in Acute Leukemia

Clinical trial NCT07188740 · RECRUITING

Trial details

NCT number: NCT07188740
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

DNMT3A Gene Mutation

Start date: 2026-08-30
Primary completion: 2027-08-30
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.